Yixing Chen

Aldolase A overexpression is associated with poor prognosis and promotes tumor progression by the epithelial-mesenchymal transition in colon cancer.

Shuyu Yang, L. Xia, Feng Ye, 2018, Biochemical and biophysical research communications.

OVOL2 attenuates the expression of MAP3K8 to suppress epithelial mesenchymal transition in colorectal cancer.

L. Xia, Q. Luo, Jin Gao, 2021, Pathology, research and practice.

ADAM9 mediates the interleukin-6-induced Epithelial-Mesenchymal transition and metastasis through ROS production in hepatoma cells.

Xiao-mei Zhao, Zhi-feng Wu, Bao-ying Yuan, 2018, Cancer letters.

Exploration of the molecular targets and mechanisms of suxiao xintong dropping pills for myocardial infarction by network pharmacology method

Shanghua Xu, Shunxiang Luo, Yanqing Wu, 2021, Bioscience reports.

MiR‐3130‐5p is an intermediate modulator of 2q33 and influences the invasiveness of lung adenocarcinoma by targeting NDUFS1

Yihua Pei, Qiyuan Li, Sheng-hua Sun, 2021, Cancer medicine.

Aldolase B impairs DNA mismatch repair and induces apoptosis in colon adenocarcinoma.

L. Xia, Lingtao Luo, Feng Ye, 2019, Pathology, research and practice.

Evaluation of the Antitumor Efficacy of RNAi-Mediated Inhibition of CDC20 and Heparanase in an Orthotopic Liver Tumor Model.

Yangde Zhang, Dong-Zhou Liu, Hu Tian, 2015, Cancer biotherapy & radiopharmaceuticals.